BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33598819)

  • 21. Frequency of BRAF V600E mutations in 969 central nervous system neoplasms.
    Behling F; Barrantes-Freer A; Skardelly M; Nieser M; Christians A; Stockhammer F; Rohde V; Tatagiba M; Hartmann C; Stadelmann C; Schittenhelm J
    Diagn Pathol; 2016 Jun; 11(1):55. PubMed ID: 27350555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glioblastoma in neurofibromatosis 1 patients without IDH1, BRAF V600E, and TERT promoter mutations.
    Shibahara I; Sonoda Y; Suzuki H; Mayama A; Kanamori M; Saito R; Suzuki Y; Mashiyama S; Uenohara H; Watanabe M; Kumabe T; Tominaga T
    Brain Tumor Pathol; 2018 Jan; 35(1):10-18. PubMed ID: 29138945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebellar glioblastoma: a clinical series with contemporary molecular analysis.
    Hong B; Banan R; Christians A; Nakamura M; Lalk M; Lehmann U; Hartmann C; Krauss JK
    Acta Neurochir (Wien); 2018 Nov; 160(11):2237-2248. PubMed ID: 30203362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BRAF V600E, TERT promoter mutations and CDKN2A/B homozygous deletions are frequent in epithelioid glioblastomas: a histological and molecular analysis focusing on intratumoral heterogeneity.
    Nakajima N; Nobusawa S; Nakata S; Nakada M; Yamazaki T; Matsumura N; Harada K; Matsuda H; Funata N; Nagai S; Nakamura H; Sasaki A; Akimoto J; Hirato J; Yokoo H
    Brain Pathol; 2018 Sep; 28(5):663-673. PubMed ID: 29105198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal Schwannoma-like Growth of multiple, multifocal BRAF V600E-positive Glioblastoma in the Interior Acoustic Canal with Leptomeningeal Infiltration: a case report.
    Jayarama-Naidu R; Gallus E
    J Med Case Rep; 2022 Feb; 16(1):50. PubMed ID: 35130969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic Resonance Imaging Reveals a Pronounced Treatment Response of a Isocitrate Dehydrogenase- and B-Raf Proto-Oncogene-Wildtype Epithelioid Glioblastoma.
    Werner JM; Brunn A; Fink GR; Galldiks N
    World Neurosurg; 2019 Jul; 127():213-215. PubMed ID: 30974270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathologic features and prognosis of epithelioid glioblastoma.
    Wang S; He Q; Zhang Q; Guan B; Zhou X
    Int J Clin Exp Pathol; 2020; 13(7):1529-1539. PubMed ID: 32782671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dabrafenib Treatment in a Patient with an Epithelioid Glioblastoma and BRAF V600E Mutation.
    Ceccon G; Werner JM; Dunkl V; Tscherpel C; Stoffels G; Brunn A; Deckert M; Fink GR; Galldiks N
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29621181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraventricular Epithelioid Glioblastoma: A Case Report.
    Nitta N; Moritani S; Fukami T; Yoshimura Y; Hirai H; Nozaki K
    World Neurosurg; 2018 Apr; 112():257-263. PubMed ID: 29425978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRAF
    Wang W; Wang M; Jiang H; Wang T; Da R
    BMC Neurol; 2021 May; 21(1):195. PubMed ID: 33980169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epithelioid GBMs show a high percentage of BRAF V600E mutation.
    Kleinschmidt-DeMasters BK; Aisner DL; Birks DK; Foreman NK
    Am J Surg Pathol; 2013 May; 37(5):685-98. PubMed ID: 23552385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathologic features and immunohistochemical spectrum of 11 cases of epithelioid malignant peripheral nerve sheath tumors, including INI1/SMARCB1 results and BRAF V600E analysis.
    Rekhi B; Kosemehmetoglu K; Tezel GG; Dervisoglu S
    APMIS; 2017 Aug; 125(8):679-689. PubMed ID: 28452074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epithelioid glioblastomas stratify into established diagnostic subsets upon integrated molecular analysis.
    Korshunov A; Chavez L; Sharma T; Ryzhova M; Schrimpf D; Stichel D; Capper D; Sturm D; Kool M; Habel A; Kleinschmidt-DeMasters BK; Rosenblum M; Absalyamova O; Golanov A; Lichter P; Pfister SM; Jones DTW; Perry A; von Deimling A
    Brain Pathol; 2018 Sep; 28(5):656-662. PubMed ID: 28990704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological characteristics of circumscribed high-grade astrocytomas with an unusual combination of BRAF V600E, ATRX, and CDKN2A/B alternations.
    Murakami C; Yoshida Y; Yamazaki T; Yamazaki A; Nakata S; Hokama Y; Ishiuchi S; Akimoto J; Shishido-Hara Y; Yoshimoto Y; Matsumura N; Nobusawa S; Ikota H; Yokoo H
    Brain Tumor Pathol; 2019 Jul; 36(3):103-111. PubMed ID: 30972500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epithelioid glioblastoma with microglia features: potential for novel therapy.
    Nakagomi N; Sakamoto D; Hirose T; Takagi T; Murase M; Nakagomi T; Yoshimura S; Hirota S
    Brain Pathol; 2020 Nov; 30(6):1119-1133. PubMed ID: 32687679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epithelioid Glioblastomas and Anaplastic Epithelioid Pleomorphic Xanthoastrocytomas--Same Entity or First Cousins?
    Alexandrescu S; Korshunov A; Lai SH; Dabiri S; Patil S; Li R; Shih CS; Bonnin JM; Baker JA; Du E; Scharnhorst DW; Samuel D; Ellison DW; Perry A
    Brain Pathol; 2016 Mar; 26(2):215-23. PubMed ID: 26238627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transformation of ganglioglioma to epithelioid glioblastoma, both with BRAF V600E mutation.
    Lau S; Clark J; Lokan J
    Pathology; 2022 Aug; 54(5):645-647. PubMed ID: 34895740
    [No Abstract]   [Full Text] [Related]  

  • 38. The post-surgical era of GBM: How molecular biology has impacted on our clinical management. A review.
    Monticelli M; Zeppa P; Zenga F; Altieri R; Mammi M; Bertero L; Castellano I; Cassoni P; Melcarne A; La Rocca G; Sabatino G; Ducati A; Garbossa D
    Clin Neurol Neurosurg; 2018 Jul; 170():120-126. PubMed ID: 29777944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of BRAF/MEK Inhibition on Epithelioid Glioblastoma with BRAFV600E Mutation: a Case Report and Review of the Literature.
    Li Y; Yang S; Hao C; Chen J; Li S; Kang Z; Kang X; Zhang H; Li W
    Clin Lab; 2020 Aug; 66(8):. PubMed ID: 32776753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers.
    Korshunov A; Ryzhova M; Hovestadt V; Bender S; Sturm D; Capper D; Meyer J; Schrimpf D; Kool M; Northcott PA; Zheludkova O; Milde T; Witt O; Kulozik AE; Reifenberger G; Jabado N; Perry A; Lichter P; von Deimling A; Pfister SM; Jones DT
    Acta Neuropathol; 2015 May; 129(5):669-78. PubMed ID: 25752754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.